Nuclear Pharmacy

 View Only
Back to discussions
Expand all | Collapse all

Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial

  • 1.  Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial

    Posted 8 days ago

    Saw this interesting article and thought I would share! 

    Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial.



    ------------------------------
    Natasha Olson, PharmD
    NCODA | Senior Manager of Member Strategy and Pharmacist Community
    509-988-3028
    ------------------------------


Related Content